(3R,8abeta)-3alpha,8,8-Trimethyl-6-methylenedecahydro-3aalpha,7alpha-methanoazulene-2-one

Details

Top
Internal ID 8eb87c7b-21dc-431e-b424-b89e773ee6d8
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Sesquiterpenoids > Cedrane and isocedrane sesquiterpenoids
IUPAC Name (1R,2R,5S,7S)-2,6,6-trimethyl-8-methylidenetricyclo[5.3.1.01,5]undecan-3-one
SMILES (Canonical) CC1C(=O)CC2C13CCC(=C)C(C3)C2(C)C
SMILES (Isomeric) C[C@H]1C(=O)C[C@@H]2[C@]13CCC(=C)[C@H](C3)C2(C)C
InChI InChI=1S/C15H22O/c1-9-5-6-15-8-11(9)14(3,4)13(15)7-12(16)10(15)2/h10-11,13H,1,5-8H2,2-4H3/t10-,11-,13-,15-/m0/s1
InChI Key QOGBNFZDBXTLSJ-UHXUCMFUSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C15H22O
Molecular Weight 218.33 g/mol
Exact Mass 218.167065321 g/mol
Topological Polar Surface Area (TPSA) 17.10 Ų
XlogP 3.20
Atomic LogP (AlogP) 3.59
H-Bond Acceptor 1
H-Bond Donor 0
Rotatable Bonds 0

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (3R,8abeta)-3alpha,8,8-Trimethyl-6-methylenedecahydro-3aalpha,7alpha-methanoazulene-2-one

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9961 99.61%
Caco-2 + 0.6778 67.78%
Blood Brain Barrier + 0.7500 75.00%
Human oral bioavailability + 0.6429 64.29%
Subcellular localzation Lysosomes 0.4547 45.47%
OATP2B1 inhibitior - 0.8498 84.98%
OATP1B1 inhibitior + 0.8701 87.01%
OATP1B3 inhibitior - 0.2258 22.58%
MATE1 inhibitior - 0.9400 94.00%
OCT2 inhibitior - 0.7500 75.00%
BSEP inhibitior - 0.8668 86.68%
P-glycoprotein inhibitior - 0.9079 90.79%
P-glycoprotein substrate - 0.8521 85.21%
CYP3A4 substrate + 0.5849 58.49%
CYP2C9 substrate - 0.7912 79.12%
CYP2D6 substrate - 0.7902 79.02%
CYP3A4 inhibition - 0.9125 91.25%
CYP2C9 inhibition - 0.8654 86.54%
CYP2C19 inhibition - 0.7327 73.27%
CYP2D6 inhibition - 0.9476 94.76%
CYP1A2 inhibition - 0.7465 74.65%
CYP2C8 inhibition - 0.9484 94.84%
CYP inhibitory promiscuity - 0.8506 85.06%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.9300 93.00%
Carcinogenicity (trinary) Non-required 0.5533 55.33%
Eye corrosion - 0.9568 95.68%
Eye irritation + 0.7809 78.09%
Skin irritation + 0.7255 72.55%
Skin corrosion - 0.9716 97.16%
Ames mutagenesis - 0.7128 71.28%
Human Ether-a-go-go-Related Gene inhibition - 0.5250 52.50%
Micronuclear - 0.9100 91.00%
Hepatotoxicity - 0.5500 55.00%
skin sensitisation + 0.8112 81.12%
Respiratory toxicity + 0.5111 51.11%
Reproductive toxicity - 0.5889 58.89%
Mitochondrial toxicity - 0.5625 56.25%
Nephrotoxicity + 0.4893 48.93%
Acute Oral Toxicity (c) III 0.6312 63.12%
Estrogen receptor binding - 0.8131 81.31%
Androgen receptor binding + 0.5471 54.71%
Thyroid receptor binding - 0.7693 76.93%
Glucocorticoid receptor binding - 0.6825 68.25%
Aromatase binding - 0.7100 71.00%
PPAR gamma - 0.7132 71.32%
Honey bee toxicity - 0.7779 77.79%
Biodegradation - 0.6500 65.00%
Crustacea aquatic toxicity + 0.7300 73.00%
Fish aquatic toxicity + 0.9847 98.47%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL253 P34972 Cannabinoid CB2 receptor 93.78% 97.25%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 93.29% 91.11%
CHEMBL1951 P21397 Monoamine oxidase A 89.35% 91.49%
CHEMBL2041 P07949 Tyrosine-protein kinase receptor RET 89.27% 91.79%
CHEMBL4685 P14902 Indoleamine 2,3-dioxygenase 88.41% 96.38%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 86.81% 95.56%
CHEMBL217 P14416 Dopamine D2 receptor 84.18% 95.62%
CHEMBL1994 P08235 Mineralocorticoid receptor 83.73% 100.00%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 83.18% 96.09%
CHEMBL2581 P07339 Cathepsin D 82.41% 98.95%
CHEMBL1907600 Q00535 Cyclin-dependent kinase 5/CDK5 activator 1 82.09% 93.03%
CHEMBL299 P17252 Protein kinase C alpha 81.35% 98.03%

Cross-Links

Top
PubChem 21576983
NPASS NPC86126
LOTUS LTS0075032
wikiData Q105224869